Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of the Female Reproductive System

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

Mitral Valve Prolapse III: Nursing Management

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Iodine-Mediated On-DNA Oxidative Cyclization of 2-Pyridylhydrazones for 1,2,4-Triazolo[4,3-<i>a</i>]pyridines.

Organic letters·2026

Same author

DNA-Compatible Synthesis of α-Aminophosphonate Scaffolds via Kabachnik-Fields Reaction.

Organic letters·2025

Same author

On-DNA Synthesis of β-Sulfonyl-α,β-Unsaturated Carbonyl Scaffolds via Hydrosulfonation of Alkynylcarbonyl Compounds.

Organic letters·2025

Same author

Molecular signals associated with intraperitoneal chemotherapy resistance in gastric cancer with peritoneal metastasis through PIPS GC trial integrated translational research.

Scientific reports·2025

Same author

Correction: Mechanical versus Bioprosthetic Aortic Valve Replacement in Patients Aged 50 to 70 Years.

Journal of chest surgery·2025

Same author

Rapid-Turnaround Co-Administration of mRNA-Based MHC-I and MHC-II-Restricted Neoantigens Enhances Immune Responses of Antigen-Specific CD8<sup>+</sup> T Cells and Anti-Cancer Efficacy in Colorectal Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Search research articles

Related Experiment Video

Updated: May 4, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Gynecologic malignancy in pregnancy.

Yong Il Ji¹, Ki Tae Kim

¹Department of Obstetrics and Gynecology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

Obstetrics & Gynecology Science

|December 12, 2013

Summary

This summary is machine-generated.

Diagnosing and treating gynecologic cancers during pregnancy requires a careful, multidisciplinary approach, considering maternal and fetal well-being. Standardized treatments are recommended, with chemotherapy and radiation timed to minimize harm to the fetus.

Keywords:

Chemotherapy Gynecologic cancer Pregnancy Radiotherapy

More Related Videos

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Related Experiment Videos

Last Updated: May 4, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Area of Science:

Oncology
Obstetrics & Gynecology

Background:

Gynecologic malignancy occurring during pregnancy presents unique diagnostic and therapeutic challenges.
A coordinated, multidisciplinary strategy is essential for optimal patient outcomes.

Purpose of the Study:

To outline the considerations for diagnosing and managing gynecologic cancers in pregnant patients.
To emphasize the importance of a tailored, multidisciplinary approach.

Main Methods:

Review of diagnostic procedures compatible with fetal safety.
Discussion of surgical interventions (laparoscopy, laparotomy) during pregnancy.
Guidance on the timing of chemotherapy and radiation therapy.
Consideration of delivery timing and pregnancy termination.

Main Results:

Diagnostic procedures can be performed safely without harming the fetus.
Surgical interventions like laparoscopy or laparotomy are feasible during pregnancy.
Chemotherapy is preferably delayed until after the first trimester, and radiation therapy postpartum.
Delivery can be postponed until 35 weeks, but termination may be necessary for immediate treatment.

Conclusions:

Management of gynecologic cancers in pregnancy necessitates a personalized, multidisciplinary approach.
Treatment strategies must account for physiological changes during pregnancy and prioritize fetal safety.
Subsequent pregnancies are not associated with an increased risk of malignancy recurrence.